Oystershell has come to an agreement with Bayer HealthCare LLC to acquire RID®, one of the leading brands in lice treatment in the US. 

RID® is known for its strong consumer brand awareness, high levels of professional endorsement and its well-respected brand logo and attributes.  In 2019, RID® achieved 25 million USD in retail sales and is the #2 brand in the US lice treatment market.

The U.S. Food and Drug Administration has approved Sklice to treat head lice for nonprescription, or over-the-counter (OTC) use. The FDA initially approved Sklice (ivermectin) lotion, 0.5% for the treatment of head lice infestation in patients 6 months of age and older as a prescription drug in February 2012.

Nuvo Pharmaceuticals have entered into an agreement with Heumann Pharma & Co GmBH Generica KC (Heumann) for the exclusive right to distribute, market and sell Resultz in Germany. Headquarterd in Nuremberg, Heumann is part of the Torrent Pharma Group.

A report by Jan Rainey published on April 29th 2018, suggests that NUVO PHARMACEUTICALS INC ORDINARY SHARES (OTCMKTS: NRIFF) had an increase of 1540% in short interest.

Nuvo Pharmaceuticals announced that it had acquired the global rights for Resultz, a head lice treatment from Piedmont Pharmaceuticals.

A new study has examined the genetic diversity of head and body lice collected from Bobigny, which is located near Paris (France), and confirmed for the first time the presence of clade E head lice in France. Clade E has upto this point been found mainly in lice from West Africa.

A new study has evaluated the response of head lice to volatiles that emanate from the human scalp, identifying the volatile components of the odor and the attractive or repellent activity of their pure main components.

A new study has assessed the in vitro efficacy of five essential oils against adults of Pediculus humanus capitis using a contact filter paper toxicity bioassay and revealed that Clove oil diluted either in coco oil or sunflower oil demonstrated the best adulticidal activity reaching over 90% within 2 hours in lice submitted to a 30 minute contact.

A new study has conclusively established for the first time that both head and body lice reproduce through paternal genome elimination (PGE), an unusual genetic system in which males transmit only their maternally derived chromosomes.

A new study aimed at assessing the in vitro pediculicidal activities of volatile oils extracted from 10 medical plants raised in Turkey has revealed that the volatile oil extract (Rosmarinus officinalis) from the rosemary medical plant was more effective than the other oils.